Sarepta Therapeutics
SRPT
#1591
Rank
โ‚น941.20 B
Marketcap
โ‚น9,853
Share price
-0.64%
Change (1 day)
-3.26%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚น206.12 Billion

According to Sarepta Therapeutics 's latest financial reports the company's total liabilities are โ‚น206.12 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Sarepta Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น200.23 B-11.8%
2022-12-31โ‚น227.01 B37.39%
2021-12-31โ‚น165.23 B1.64%
2020-12-31โ‚น162.57 B126.93%
2019-12-31โ‚น71.64 B68.02%
2018-12-31โ‚น42.63 B28.73%
2017-12-31โ‚น33.12 B457.6%
2016-12-31โ‚น5.94 B7.13%
2015-12-31โ‚น5.54 B84.65%
2014-12-31โ‚น3.00 B9.53%
2013-12-31โ‚น2.74 B-38.42%
2012-12-31โ‚น4.45 B260.42%
2011-12-31โ‚น1.23 B-43.5%
2010-12-31โ‚น2.18 B29.46%
2009-12-31โ‚น1.68 B258.39%
2008-12-31โ‚น0.47 B-2.03%
2007-12-31โ‚น0.48 B244.67%
2006-12-31โ‚น0.13 B12.85%
2005-12-31โ‚น0.12 B26.93%
2004-12-31โ‚น97.42 M-42.95%
2003-12-31โ‚น0.17 B-30.47%
2002-12-31โ‚น0.24 B55.15%
2001-12-31โ‚น0.15 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น3.130 T 1,419.00%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น193.99 B-5.88%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น11.90 B-94.22%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น83.16 B-59.65%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น361.55 B 75.41%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น250.98 B 21.76%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น135.99 B-34.02%๐Ÿ‡บ๐Ÿ‡ธ USA